Search research articles
Contact Us
Filters
Showing results (161-170 of 306) with videos related to
Page
of 31
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 16, 2010
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology
|
April 17, 2013
Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1
Norio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
Journal of Clinical Microbiology
|
November 8, 2013
Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection
Norio Akuta, Fumitaka Suzuki, Taito Fukushima, et al.
Internal Medicine (Tokyo, Japan)
|
November 21, 2007
Prolonged hepatitis after acute infection with genotype H hepatitis B virus
Norio Chihara, Yasuji Arase, Fumitaka Suzuki, et al.
Virology Journal
|
December 25, 2015
Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
Keiichi Masaki, Fumitaka Suzuki, Tasuku Hara, et al.
Hepatology Communications
|
February 7, 2018
Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies
Norio Akuta, Chizuru Watanabe, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 21, 2018
Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
Yasue Takeuchi, Norio Akuta, Hitomi Sezaki, et al.
Journal of Medical Virology
|
February 19, 2010
Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin
Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Journal of Gastroenterology
|
March 2, 2022
The useful predictors of zinc deficiency for the management of chronic liver disease
Soichi Iritani, Yusuke Kawamura, Nozomu Muraishi, et al.
Journal of Gastroenterology
|
August 5, 2003
Clinical features of hepatitis B virus genotype A in Japanese patients
Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 306) with videos related to
Sort By:
Page
of 31
Liver International : Official Journal of the International Association for the Study of the Liver
|
September 16, 2010
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Journal of Medical Virology
|
April 17, 2013
Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1
Norio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
Journal of Clinical Microbiology
|
November 8, 2013
Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection
Norio Akuta, Fumitaka Suzuki, Taito Fukushima, et al.
Internal Medicine (Tokyo, Japan)
|
November 21, 2007
Prolonged hepatitis after acute infection with genotype H hepatitis B virus
Norio Chihara, Yasuji Arase, Fumitaka Suzuki, et al.
Virology Journal
|
December 25, 2015
Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection
Keiichi Masaki, Fumitaka Suzuki, Tasuku Hara, et al.
Hepatology Communications
|
February 7, 2018
Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies
Norio Akuta, Chizuru Watanabe, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 21, 2018
Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
Yasue Takeuchi, Norio Akuta, Hitomi Sezaki, et al.
Journal of Medical Virology
|
February 19, 2010
Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin
Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Journal of Gastroenterology
|
March 2, 2022
The useful predictors of zinc deficiency for the management of chronic liver disease
Soichi Iritani, Yusuke Kawamura, Nozomu Muraishi, et al.
Journal of Gastroenterology
|
August 5, 2003
Clinical features of hepatitis B virus genotype A in Japanese patients
Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, et al.
Page
of 31